Albendazole 400 mg Tablet – Broad-Spectrum Anthelmintic Medicine
Buy Albendazole 400 mg from Tabexports – Worldwide Pharmaceutical Exporter
Albendazole 400 mg Tablet is a widely used broad-spectrum anthelmintic medication indicated for the treatment of various intestinal and tissue parasitic worm infections. It is effective against roundworms, hookworms, pinworms, tapeworms, and hydatid disease when used under professional medical supervision.
Tabexports supplies Albendazole 400 mg tablets for bulk and wholesale export, ensuring export-compliant packaging, regulatory documentation, and reliable worldwide distribution.
Active Ingredient
Albendazole 400 mg
Albendazole belongs to the benzimidazole class of anthelmintics and acts by inhibiting parasite microtubule synthesis, leading to parasite death.
Product Highlights
✔ Albendazole 400 mg standard deworming strength
✔ Broad-spectrum activity against intestinal & tissue parasites
✔ Commonly used in mass deworming programs (as prescribed)
✔ WHO-recognized anthelmintic medicine
✔ Export-ready international pharmaceutical packaging
✔ Bulk & wholesale supply available worldwide
Mechanism of Action
Albendazole works by:
-
Disrupting parasite microtubule formation
-
Blocking glucose uptake in parasites
-
Causing energy depletion and parasite death
Use strictly under licensed medical supervision.
Dosage & Administration
-
Dosage as prescribed by a healthcare professional
-
Depends on parasite type and infection severity
-
May be given as a single dose or multi-day regimen
-
Complete the full prescribed treatment course
Storage & Safety Information
-
Store in a cool, dry place
-
Protect from light and moisture
-
Keep out of reach of children
-
Prescription use recommended
Why Choose Tabexports?
🌍 Trusted global pharmaceutical exporter
📦 Export-grade packaging & regulatory documentation
🚚 Reliable international logistics network
🏭 Quality-controlled manufacturing sources
📈 Bulk supply for distributors, hospitals, NGOs & public health programs





Reviews
There are no reviews yet.